Congenital toxoplasmosis.
D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000628:therapy; D014123:Toxoplasmosis / Q000191:economics / Q000628:therapy; D014125:Toxoplasmosis, Congenital / Q000517:prevention & control*; D006113:United Kingdom